Despite being announced as a global health concern and emergency in January by WHO, designing specific treatment for SARS-CoV-2 is still a summit yet to be conquered. Currently, many drugs are being tested in the clinical scenario and vitamins play a significant role in therapeutic management. Based on the available evidence, we postulate that maintaining normal vitamin D3 levels may reduce severity, mortality risk of COVID-19. This review elucidates the alarming need for randomized clinical trials to determine the role of vitamin D in patient prognosis in COVID-19 infection and on latitude bases epidemiological outcome.
Description
Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling - ScienceDirect
%0 Journal Article
%1 lahoorbasha2021shielding
%A Lahoor Basha, Shaik
%A Suresh, Sake
%A Ashok Reddy, V.V.
%A Surya Teja, S P
%D 2021
%J Clinical Epidemiology and Global Health
%K Vit_D covid-19
%P 326 - 331
%R https://doi.org/10.1016/j.cegh.2020.10.005
%T Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling
%U http://www.sciencedirect.com/science/article/pii/S2213398420302256
%V 9
%X Despite being announced as a global health concern and emergency in January by WHO, designing specific treatment for SARS-CoV-2 is still a summit yet to be conquered. Currently, many drugs are being tested in the clinical scenario and vitamins play a significant role in therapeutic management. Based on the available evidence, we postulate that maintaining normal vitamin D3 levels may reduce severity, mortality risk of COVID-19. This review elucidates the alarming need for randomized clinical trials to determine the role of vitamin D in patient prognosis in COVID-19 infection and on latitude bases epidemiological outcome.
@article{lahoorbasha2021shielding,
abstract = {Despite being announced as a global health concern and emergency in January by WHO, designing specific treatment for SARS-CoV-2 is still a summit yet to be conquered. Currently, many drugs are being tested in the clinical scenario and vitamins play a significant role in therapeutic management. Based on the available evidence, we postulate that maintaining normal vitamin D3 levels may reduce severity, mortality risk of COVID-19. This review elucidates the alarming need for randomized clinical trials to determine the role of vitamin D in patient prognosis in COVID-19 infection and on latitude bases epidemiological outcome.},
added-at = {2020-12-27T18:52:58.000+0100},
author = {{Lahoor Basha}, Shaik and Suresh, Sake and {Ashok Reddy}, V.V. and {Surya Teja}, S P},
biburl = {https://www.bibsonomy.org/bibtex/2ff96e633a01b85bcbd445fa744e3db6c/fordham1},
description = {Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling - ScienceDirect},
doi = {https://doi.org/10.1016/j.cegh.2020.10.005},
interhash = {6e4a89a2633881d15eacbaac951ea574},
intrahash = {ff96e633a01b85bcbd445fa744e3db6c},
issn = {2213-3984},
journal = {Clinical Epidemiology and Global Health},
keywords = {Vit_D covid-19},
pages = {326 - 331},
timestamp = {2020-12-27T18:52:58.000+0100},
title = {Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling},
url = {http://www.sciencedirect.com/science/article/pii/S2213398420302256},
volume = 9,
year = 2021
}